4//SEC Filing
GROENHUYSEN WILCO 4
Accession 0001416038-11-000003
CIK 0000873364other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 12:12 PM ET
Size
21.0 KB
Accession
0001416038-11-000003
Insider Transaction Report
Form 4
CEPHALON INCCEPH
GROENHUYSEN WILCO
Exec. V.P., CFO
Transactions
- Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−18,000→ 0 totalExercise: $56.07From: 2013-12-02Exp: 2019-12-02→ Common Stock (18,000 underlying) - Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−4,300→ 0 totalExercise: $73.04From: 2011-11-07Exp: 2017-11-07→ Common Stock (4,300 underlying) - Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−5,200→ 0 totalExercise: $73.25From: 2012-12-11Exp: 2018-12-11→ Common Stock (5,200 underlying) - Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−15,000→ 0 totalExercise: $59.03From: 2013-07-30Exp: 2019-07-30→ Common Stock (15,000 underlying) - Disposition to Issuer
Incentive Stock Option
2011-10-14−6,336→ 0 totalExercise: $63.11From: 2014-12-16Exp: 2020-12-16→ Common Stock (6,336 underlying) - Disposition to Issuer
Common Stock
2011-10-14−42,717→ 0 total - Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−1,800→ 0 totalExercise: $76.11From: 2011-12-13Exp: 2017-12-13→ Common Stock (1,800 underlying) - Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−43,664→ 0 totalExercise: $63.11From: 2014-12-16Exp: 2020-12-16→ Common Stock (43,664 underlying)
Footnotes (4)
- [F1]Common Stock was converted pursuant to the Agreement and Plan of Merger, dated as of May 1, 2011, among Teva Pharmaceutical Industries Ltd., Copper Acquisition Corp. and Cephalon, Inc. (the "Merger Agreement") into the right to receive the Merger Consideration (as defined in the Merger Agreement) of $81.50 per share in cash.
- [F2]Includes 20,425 shares of Restricted Stock with certain vesting restrictions, which restrictions lapsed under the terms of the Merger Agreement at the Effective Time of the Merger.
- [F3]Options were canceled at the Effective Time of the Merger pursuant to the terms of the Merger Agreement in exchange for a cash payment for each share subject to the option equal to the difference between the Merger Consideration of $81.50 per share and the exercise price of the option.
- [F4]Reflects four-year anniversary from date of grant. Options vest 25% on each anniversary of grant and expire ten years from date of grant.
Documents
Issuer
CEPHALON INC
CIK 0000873364
Entity typeother
Related Parties
1- filerCIK 0001483425
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 12:12 PM ET
- Size
- 21.0 KB